 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- CD19-CAR-T2 cells / Southern Medical University
Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement (Halls G-H (San Diego Convention Center)) - Nov 3, 2023 - Abstract #ASH2023ASH_4429;
P2
The cells were expanded ex vivo and administered in a single infusion (1
- | CD19-CAR-T2 cells / Southern Medical University
Trial completion date, Trial primary completion date, CAR T-Cell Therapy: CD19-CAR-T2 Cells for CD19 Positive Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Mar 20, 2023
P2, N=60, Recruiting, Sponsor: Nanfang Hospital of Southern Medical University
The cells were expanded ex vivo and administered in a single infusion (1 Trial completion date: Jun 2021 --> Dec 2023 | Trial primary completion date: Dec 2020 --> Jun 2023
- | CD19-CAR-T2 cells / Southern Medical University
New P2 trial, CAR T-Cell Therapy: CD19-CAR-T2 Cells for CD19 Positive Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Oct 27, 2020
P2, N=60, Recruiting, Sponsor: Nanfang Hospital of Southern Medical University